Search details
1.
A cross-sectional study of the prevalence and clinical management of atherosclerotic cardiovascular diseases in patients with type 2 diabetes across the Middle East and Africa (PACT-MEA): Study design and rationale.
Diabetes Obes Metab
; 25(6): 1444-1452, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36775980
2.
Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.
Circulation
; 147(16): 1251-1255, 2023 04 18.
Article
in English
| MEDLINE | ID: mdl-36877670
3.
A Jordanian Multidisciplinary Consensus Statement on the Management of Dyslipidemia.
J Clin Med
; 12(13)2023 Jun 27.
Article
in English
| MEDLINE | ID: mdl-37445345
4.
The past decade in type 2 diabetes and future challenges.
Hormones (Athens)
; 17(4): 451-459, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30519831
5.
Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS).
Int J Cardiol
; 110(2): 179-83, 2006 Jun 16.
Article
in English
| MEDLINE | ID: mdl-16233922
6.
Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study.
Vasc Health Risk Manag
; 11: 149-55, 2015.
Article
in English
| MEDLINE | ID: mdl-25750538
7.
Achieving low-density lipoprotein cholesterol treatment goals among dyslipidemic individuals in the Levant: the CEntralized Pan-Levant survey on tHE Undertreatment of hypercholeSterolemia (CEPHEUS) study.
Curr Med Res Opin
; 30(10): 1957-65, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24889279
8.
Insulin detemir in the management of type 2 diabetes in non-Western countries: safety and effectiveness data from the A1chieve observational study.
Diabetes Res Clin Pract
; 101(3): 317-25, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-24119589
9.
Safety and effectiveness of bolus insulin aspart in people with type 2 diabetes: a1chieve sub-analysis.
Diabetes Ther
; 4(1): 153-66, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23757032
10.
Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen.
Diabetes Ther
; 4(2): 309-19, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23846835
11.
Safety and effectiveness of biphasic insulin aspart 30 in different age-groups: a1chieve sub-analysis.
Diabetes Ther
; 4(2): 347-61, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23860823
12.
Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries.
Diabetes Ther
; 4(1): 91-102, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23645286
13.
Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.
Diabetes Ther
; 4(2): 399-408, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24108581
14.
Switching from biphasic human insulin 30 to biphasic insulin aspart 30 in type 2 diabetes is associated with improved glycaemic control and a positive safety profile: results from the A1chieve study.
Diabetes Res Clin Pract
; 98(3): 408-13, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23217267
15.
The A1chieve study: a 60 000-person, global, prospective, observational study of basal, meal-time, and biphasic insulin analogs in daily clinical practice.
Diabetes Res Clin Pract
; 88 Suppl 1: S11-6, 2010 May.
Article
in English
| MEDLINE | ID: mdl-20466163
Results
1 -
15
de 15
1
Next >
>>